Table 1 Association between SNHG12 expression levels (ΔCt) and clinical-pathological factors
From: Network analysis of KLF5 targets showing the potential oncogenic role of SNHG12 in colorectal cancer
Characteristics | No. of patients (%) | SNHG12 (Mean ± SD) | p-value |
|---|---|---|---|
Age (year) | |||
 ≥ 60 | 67 (60.4) | 5.25 ± 2.19 | 0.953 |
 < 60 | 44 (39.6) | 5.23 ± 2.27 | |
Gender | |||
 Male | 66 (59.5) | 5.27 ± 1.97 | 0.886 |
 Female | 45 (40.5) | 5.21 ± 2.54 |  |
Tumor location | |||
 Colon | 54 (48.6) | 4.95 ± 2.22 | 0.169 |
Rectal | 57 (51.4) | 5.53 ± 2.18 |  |
Diameter (cm) | |||
 > 5 | 28 (25.2) | 5.12 ± 2.19 | 0.731 |
 ≤ 5 | 83 (74.8) | 5.29 ± 2.23 | |
Differentiation | |||
 Well | 4 (3.6) | 4.49 ± 2.04 | 0.692 |
 Moderate | 87 (78.4) | 5.22 ± 2.25 | |
 Poor | 20 (18.0) | 5.50 ± 2.11 | |
Invasion | |||
 T1 | 7 (6.3) | 6.79 ± 2.49 | 0.047* |
 T2 | 23 (20.7) | 5.41 ± 2.24 | |
 T3 | 16 (14.4) | 5.91 ± 2.61 | |
 T4 | 65 (58.6) | 4.80 ± 1.92 | |
Lymph node metastasis | |||
 N0 | 57 (51.4) | 5.35 ± 2.25 | 0.253 |
 N1 | 31 (27.9) | 5.55 ± 2.26 | |
 N2 | 23 (20.7) | 4.58 ± 1.97 | |
Distal metastasis | |||
 M 0 | 102 (91.9) | 5.36 ± 2.20 | 0.030* |
 M 1 | 9 (8.1) | 3.70 ± 1.68 |  |
TNM stage | |||
 I | 21 (18.9) | 5.56 ± 2.21 | 0.256 |
 II | 36 (32.4) | 5.21 ± 2.30 | |
 III | 44 (39.6) | 5.41 ± 2.18 | |
 IV | 10 (9.0) | 3.96 ± 1.78 | |